3-(4-Hydroxymethylbenzoyl)-1-pentylindole explained

3-(4-Hydroxymethylbenzoyl)-1-pentylindole is a synthetic cannabinoid. It is planned to be scheduled (in group I-N) in Poland.^[1] It has been reported to the EMCDDA and Europol for the first time in 2010^[2] under the terms of European Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances.^[3]

See also

• Synthetic cannabis

Notes and References

1. http://www.mz.gov.pl/wwwmz/index?mr=q491&ms=382&ml=pl&mi=382&mx=0&mt=&my=131&ma=030747 http://www.mz.gov.pl/wwwfiles/ma_struktura/docs/ustawa_narkoman_201209171553.pdf "[E]kspertyza [opracowana] przez Katedrę i Zakład Farmakologii Doświadczalnej i Klinicznej Warszawskiego Uniwersytetu Medycznego [...] potwierdziła zasadność objęcia kontrolą ustawową [...] syntetycznych kanabinoidów: JWH-015, JWH-098, JWH-251, JWH-307, AM-2201, 3-(4-hydroksymetylobenzoilo)-1-pentyloindol" ("Department of Experimental and Clinical Pharmacology of Medical University of Warsaw evaluated that synthetic cannabinoids JWH-015, JWH-098, JWH-251, JWH-307, AM-2201, 3-(4-hydroxymethylbenzoyl)-1-pentylindole need to be scheduled.", accessed 30 April 2013)
2. Web site: Annex 2 New psychoactive substances reported to the EMCDDA and Europol for the first time in 2010 under the terms of Council Decision 2005/387/JHA . European Monitoring Centre for Drugs and Drug Addiction.
3. Web site: 32005D0387 - EN - EUR-Lex: European Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances . EUR-Lex . 2005-05-10 . af . 2021-11-24.